Get the Stockscreener App
54.04
0.52%
0.28
After Hours:
54.04
Azenta Inc stock is traded at $54.04, with a volume of 548.59K.
It is up +0.52% in the last 24 hours and up +4.14% over the past month.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has two reportable segments that are Life Sciences Products and Life Sciences Services. It generates a substantial part of its revenue from its Life Sciences Services segment.
See More
Previous Close:
$53.76
Open:
$54.38
24h Volume:
548.59K
Relative Volume:
0.77
Market Cap:
$2.64B
Revenue:
$656.32M
Net Income/Loss:
$-164.17M
P/E Ratio:
-18.14
EPS:
-2.9794
Net Cash Flow:
$12.90M
1W Performance:
+0.24%
1M Performance:
+4.14%
6M Performance:
-7.37%
1Y Performance:
-19.00%
1-Day Range:
$53.59
$55.63
1-Week Range:
$47.14
$55.63
52-Week Range:
$38.82
$67.77
Azenta Inc Stock (AZTA) Company Profile
Name
Azenta Inc
Sector
Industry
Phone
(978) 262-2400
Address
200 SUMMIT DRIVE, BURLINGTON
Compare AZTA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AZTA
Azenta Inc
|
54.04 | 2.64B | 656.32M | -164.17M | 12.90M | -2.9794 |
|
ISRG
Intuitive Surgical Inc
|
588.50 | 209.89B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
227.21 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
91.65 | 45.33B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
237.18 | 34.84B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
330.47 | 23.97B | 2.88B | 499.60M | 321.60M | 6.74 |
Azenta Inc Stock (AZTA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-18-24 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-04-24 | Initiated | Jefferies | Hold |
| Feb-01-24 | Reiterated | B. Riley Securities | Buy |
| Jul-19-23 | Initiated | Raymond James | Mkt Perform |
| May-10-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-09-23 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Mar-31-22 | Resumed | B. Riley Securities | Buy |
| Mar-21-22 | Initiated | Evercore ISI | Outperform |
View All
Azenta Inc Stock (AZTA) Latest News
Azenta, Inc. Shows Positive Outlook in Earnings Call - TipRanks
Conestoga Capital Advisors LLC Increases Stock Position in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Azenta (NASDAQ:AZTA) Releases Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
Azenta stock price target raised to $52 at Jefferies - MSN
Azenta Inc (AZTA) expanding its growth trajectory ahead - SETE News
A Glimpse Into The Expert Outlook On Azenta Through 4 Analysts - Benzinga
Long AZTA: Azenta Inc. Rebounds from $50 Support, Eyes $60 Target Amid Positive Q1 Results - Invezz
Azenta Inc (AZTA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic Challenges - Yahoo Canada Finance
Azenta, Inc. Reports Strong Q1 2025 Results - TipRanks
The Attractiveness of Investing In Azenta Inc (AZTA) is Growing - Knox Daily
Azenta reiterates 2025 guidance with 3-5% organic growth and EBITDA margin expansion - MSN
Azenta stock price target raised to $59 at Needham - Investing.com
Brooks: Fiscal Q1 Earnings Snapshot -February 05, 2025 at 07:30 am EST - Marketscreener.com
Azenta’s (NASDAQ:AZTA) Q4 Sales Top Estimates - Yahoo Finance
Azenta Inc Reiterates FY 2025 Revenue Guidance Of 3% To 5% Organic Growth -February 05, 2025 at 07:38 am EST - Marketscreener.com
Earnings Flash (AZTA) AZENTA Reports Q1 Adjusted EPS $0.08, vs. FactSet Est of $0.10 - Marketscreener.com
Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024 - PR Newswire
Azenta, Inc. (NASDAQ:AZTA) Short Interest Down 7.2% in January - MarketBeat
Is Azenta (AZTA) the Mid-Cap Stock Insiders Are Buying Recently? - Insider Monkey
Loss-making Azenta (NASDAQ:AZTA) sheds a further US$110m, taking total shareholder losses to 40% over 3 years - Simply Wall St
Azenta eyes streamlined focus, plans B Medical segment sale - MSN
16,253 Shares in Azenta, Inc. (NASDAQ:AZTA) Bought by SG Americas Securities LLC - MarketBeat
Azenta Inc (AZTA) Reports Q4 Revenue of $150.83M, EPS of -$0.11, Surpassing Estimates - GuruFocus.com
Revolutionizing Biotech: Dipal Doshi Joins Azenta's Board of Directors! - Clinique Bio
Azenta elects Entrada CEO to Board of Directors - MSN
Azenta elects Entrada CEO to Board of Directors By Investing.com - Investing.com Canada
Azenta eyes streamlined focus, plans B Medical segment sale By Investing.com - Investing.com South Africa
Azenta Announces the Election of Dipal Doshi to its Board of Directors - StreetInsider.com
Rising Biotech Leader Joins Azenta Board: Strategic Move Signals Growth Ambitions - StockTitan
SG Americas Securities LLC Makes New Investment in Azenta, Inc. (NASDAQ:AZTA) - Defense World
Azenta (AZTA) Projected to Post Quarterly Earnings on Wednesday - Defense World
Azenta Announces Fiscal 2025 First Quarter Earnings Conference Call and Webcast - BioSpace
Azenta: Taking A Pass (NASDAQ:AZTA) - Seeking Alpha
Azenta, Inc. (NASDAQ:AZTA) Stock Position Cut by Park Avenue Securities LLC - Defense World
4,003 Shares in Azenta, Inc. (NASDAQ:AZTA) Bought by Assenagon Asset Management S.A. - Defense World
Exchange Traded Concepts LLC Boosts Stock Holdings in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence - PR Newswire
PR News Wire SpaceDaily.com Widget Page - Space Daily
Azenta Wins Major UK Biocentre Contract for 16M-Sample Storage System Expansion - StockTitan
Bullish Azenta Insiders Loaded Up On US$1.29m Of Stock - Yahoo Finance
Oak Thistle LLC Acquires New Shares in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Clinical-grade long-read sequencing test gains US regulatory approval - Labmate Online
GAMMA Investing LLC Sells 334 Shares of Azenta, Inc. (NASDAQ:AZTA) - Defense World
At US$51.81, Is Azenta, Inc. (NASDAQ:AZTA) Worth Looking At Closely? - Simply Wall St
Azenta (NASDAQ:AZTA) Given Overweight Rating at Stephens - Defense World
Azenta's (AZTA) "Overweight" Rating Reiterated at Stephens - MarketBeat
Azenta, Inc. (NASDAQ:AZTA) Shares Sold by Principal Financial Group Inc. - MarketBeat
Principal Financial Group Inc. Sells 67,809 Shares of Azenta, Inc. (NASDAQ:AZTA) - Defense World
Short Interest in Azenta, Inc. (NASDAQ:AZTA) Drops By 6.9% - Defense World
Azenta Inc Stock (AZTA) Financials Data
Revenue
Net Income
Cash Flow
EPS
10.10%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):